Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

News

  • Home
  •  
  • News



  • Most Read
  • Latest Comments
  • Imugene Advances Cancer Fight with 57% Complete Response Rate in CAR-T Trial
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Imugene Advances Cancer Fight with 57% Complete Response Rate in CAR-T Trial
    • News

    Smart pain assessment app now used by more than half of Australia’s residential aged care providers
    Public
  • Imugene Advances Cancer Fight with 57% Complete Response Rate in CAR-T Trial
    • News

    Fledgling fintech hopes millennials put their Douugh into micro-investing ‘super’ app
    Public
  • Imugene Advances Cancer Fight with 57% Complete Response Rate in CAR-T Trial
    • News

    🎵 The knee bone’s connected to the… collagen rope device (?!)
    Public
  • Imugene Advances Cancer Fight with 57% Complete Response Rate in CAR-T Trial
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial
    • Review
    • September 1, 2022

Latest Articles

  • Imugene Advances Cancer Fight with 57% Complete Response Rate in CAR-T Trial
    Imugene Advances Cancer Fight with 57% Complete Response Rate in CAR-T Trial
    • News

  • Issues clinical trial update of its Phase 1 MAST trial
    Issues clinical trial update of its Phase 1 MAST trial
    • News

  • Harris Technology sees earnings boost after strategic pivot amid economic challenges
    • News

    Harris Technology sees earnings boost after strategic pivot amid economic challenges

    Online retailer Harris Technology (ASX: HT8) has seen a significant improvement in earnings after repositioning its business strategy to counter the adverse effects of declining discretionary spending. The Company’s strategic shift, aimed at navigating a difficult economic climate where Australian households have pulled back on spending, has helped boost margins and earnings despite a reduction

    Read More
    Public
  • Seafarms gains momentum with prawn exports to Europe, but struggles persist
    • News

    Seafarms gains momentum with prawn exports to Europe, but struggles persist

    Aquaculture company Seafarms Group (ASX: SFG) is gaining traction in its prawn export business, particularly in Europe, but the overall performance of the Company continues to struggle as it battles financial issues following an adverse Federal Court ruling in February 2024.  In it’s FY24 results for the year ended 30 June 2024, the Company reported

    Read More
    Public
  • BlueBet concedes there is no profitable path to the US, exits amid costly regulatory challenges
    • News

    BlueBet concedes there is no profitable path to the US, exits amid costly regulatory challenges

    Fresh off their merger with betr, which will see a combined business rebrand shortly, wagering operator BlueBet (ASX: BBT) has confirmed its decision to concede it’s international expansion ambitions by exiting the US market and concentrating solely on Australia.  The move mirrors a trend seen among smaller Australian betting firms like PointsBet (ASX: PBH), which

    Read More
    Public
  • BTC Health drives earnings with product diversification to all major hospital operators
    • News

    BTC Health drives earnings with product diversification to all major hospital operators

    It turns out that the departure of a significant partner can be a blessing in disguise, as demonstrated by medical distribution company BTC Health (ASX: BTC), which has delivered revenue and earnings growth through a series of measures implemented through FY24 to reduce their reliance on their previously biggest supplier.  In April 2023, BTC confirmed

    Read More
    Public
  • Interest in captioning tech sees jump in earnings for AI-Media
    • News

    Interest in captioning tech sees jump in earnings for AI-Media

    In a world increasingly dependent on digital communication, AI-Media Technologies (ASX: AIM) is striving to enhance the way we interact with content. With a focus on AI-powered solutions that transform the landscape of captioning, transcription, and translation, AI-Media has demonstrated growth in its key financial metrics for the year ending June 30,2024.  AIM’s total revenue

    Read More
    Public
  • Despite construction industry challenges, Duratec delivers earnings growth
    • News

    Despite construction industry challenges, Duratec delivers earnings growth

    The Australian construction market has seen a range of challenges from raw material costs rises, but also opportunities from a need for better infrastructure to service population growth. Despite the dynamic environment in the Australian construction market, the demand for high-quality engineering and remediation services has driven Duratec’s (ASX: DUR) revenue and earnings growth for

    Read More
    Public
  • Tabcorp faces profit erosion amid declining horse racing wagering as focus shifts to sports betting
    • News

    Tabcorp faces profit erosion amid declining horse racing wagering as focus shifts to sports betting

    In his first results presentation since taking the helm of wagering operator Tabcorp (ASX: TAH), former AFL boss Gillon McLaughlan has not shied away from the Company’s overreliance on horse racing which is a sport in turmoil as wagering numbers have plummeted, prompting McLaughlan to drive a greater push for Tabcorp towards general sports.  For

    Read More
    Public
  • AI-powered road safety solutions pave the way for Acusensus revenue bump
    • News

    AI-powered road safety solutions pave the way for Acusensus revenue bump

    Despite economic uncertainties, the demand for road safety solutions continues to grow, contributing to Acusensus’s (ASX: ACE) revenue and earnings for FY24 Founded in 2018, Acusensus designs and develops artificial intelligence-enabled road safety solutions. The Company’s financial performance highlights its focus on strategic initiatives, with an 18% annual increase in revenue to $49.6 million. The

    Read More
    Public
  • Archer begins new experiments for its lab-on-a-chip for kidney disease detection
    • News

    Archer begins new experiments for its lab-on-a-chip for kidney disease detection

    According to the Australian Institute of Health and Welfare, there are more than 1.7 million Australians that live with the biomedical signs of chronic kidney disease. While not all will deteriorate to kidney failure, it leads to the 22,000 deaths annually which could be reduced from earlier detection and better management, an initiative launched by

    Read More
    Public
  • Auswide Bank profits dip with loan book stagnation, growth to come following MyState merger
    • News

    Auswide Bank profits dip with loan book stagnation, growth to come following MyState merger

    While Australians have been increasingly frustrated by the Big Four banks and their inability to connect with customers, the trends have not played in the favour of minnow Auswide Bank (ASX: ABA) which has seen a dip in earnings, something that will be addressed through their proposed merger with fellow minnow MyState Bank (ASX: MYS). 

    Read More
    Public
  • «
  • ‹
  • 21
  • 22
  • 23
  • 24
  • 25
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.